Cost-Effectiveness Model Comparing Olanzapine and Other Oral Atypical Antipsychotics in the Treatment of Schizophrenia in the United States
Cost Effectiveness and Resource Allocation - United Kingdom
doi 10.1186/1478-7547-7-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2009
Authors
Publisher
Springer Science and Business Media LLC